Smoking CessationNCT06570122
Mobile Phone-Based Smoking-Cessation Intervention for Smoking Parents
A study testing 5A's/5R's advice, Health warning leaflet and AI-powered chatbot support in people with Smoking Cessation, run by Beijing Normal University at 1 site in China.
Trial summary
This study aims to explore the feasibility and preliminary effectiveness of a mobile phone-based intervention tailored specifically for smoking parents. Read more about this study
- Who is it for?
- Ages 18 years and olderHealthy volunteers can take part
- Conditions the study is for
- Smoking Cessation
- What is being tested?
- 5A's/5R's advice, Health warning leaflet and AI-powered chatbot support
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 300 participants
- Where
- 1 siteChina
- Study dates
- 1 Sep 2025to 30 Dec 2027
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- Healthy volunteers accepted
- Adult, Older adult
Who may be able to join
- aged 18 and above, reside in Zhuhai for the next 6 months
- smoke at least 1 cigarette or use e-cigarettes daily
- have a smartphone and a WeChat account, able to use WeChat skillfully
Who cannot join
- Smokers who have communication barrier (either physically or cognitively)
- Smokers who are currently participating in other SC programmes or services
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
China1 site, 1 recruiting
- Recruiting
Beijing Normal University
Zhuhai, Guangdong, 519087
Xue Weng, xueweng@bnu.edu.cn
About this study
Official title: Effectiveness of AI-powered Mobile Phone-based Interventions in Parental Smoking Cessation
This study aims to explore the feasibility and preliminary effectiveness of a mobile phone-based intervention tailored specifically for smoking parents.
Read the detailed description
Parental smoking is associated with numerous adverse outcomes, including exposure to secondhand smoke, heightened risk of respiratory illnesses in children, and an increased likelihood that children will adopt smoking behaviors themselves. Despite awareness of these risks, many parents find it challenging to quit smoking due to stress, lack of support, and time constraints.
This randomized controlled trial (RCT) investigates the effectiveness of a mobile phone-based intervention tailored specifically for smoking parents. The intervention group will receive AI-powered chatbot cessation support, while the control group will be provided with brief cessation advice. The study aims to determine whether the AI-driven intervention is more effective in helping parents quit smoking compared to traditional brief advice.
- Conditions
- Smoking Cessation
- Being tested
- 5A's/5R's advice, Health warning leaflet, AI-powered chatbot support
- Medical subject headings
- Smoking Cessation
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
5A's/5R's adviceBehavioural
5A's (Ask, Advise, Assess, Assist, Arrange) for smokers who are ready to quit, and 5R's (relevance, risks, rewards, roadblocks, and repetition) for smokers who are not ready to quit.
Health warning leafletOther
The health warning leaflet provides essential information on the dangers of secondhand and thirdhand smoke. It outlines how exposure to these forms of smoke can harm both smokers and non-smokers, particularly children, by increasing the risk of respiratory illnesses and other health issues.
AI-powered chatbot supportBehavioural
Participants will receive three months of AI-powered chatbot, equipped with personalized interactions and real-time support, via WeChat.
| Study group | Role | What they receive |
|---|---|---|
| AI chatbot support group | Experimental | AI-powered chatbot support+ 5A's/5R's advice + health warning leaflet Receives: Behavioral: 5A's/5R's advice; Other: Health warning leaflet; Behavioral: AI-powered chatbot support |
| Control group | Active comparator | 5A's/5R's advice + health warning leaflet Receives: Behavioral: 5A's/5R's advice; Other: Health warning leaflet |
What is being measured
The primary outcome is the main question the study is designed to answer.
Self-reported 7-day point prevalence quit rate
Self-reported 7-day point prevalence quit rate in the two groups
Measured: 3 and 6 months follow-up
Eligibility rate
the percentage of eligible smokers out of the total number of smokers screened
Measured: baseline
Secondary outcomes (2)
Consent rate
the percentage of eligible smokers who agree to participate out of the total number of eligible smokers
Measured: baseline
Percentage of Participant Engagement with E-Messages and Counselor Chats
This outcome measures the percentage of participants who engage with the intervention by reading e-messages and responding to counselor chat messages at least once during the 3-month follow-up period.
Measured: 3 months follow-up
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted26 Aug 2024
- Study start1 Sep 2025
- Primary completion30 Dec 2026 (estimated)
- Study completion30 Dec 2027 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Smoking CessationStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind
- Who is masked
- Outcomes assessor
- Enrolment
- 300 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Beijing Normal University
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06570122
- Sponsor's protocol ID
- mCessation in smoking parents
- Status last verified
- Aug 2026
- First submitted
- 16 Aug 2024
- Last updated
- 2 Sep 2026
- Results posted
- No
- Data monitoring committee
- Yes
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 2 Sep 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Effectiveness of AI-powered Mobile Phone-based Interventions in Parental Smoking Cessation
- ClinicalTrials.gov ID
- NCT06570122
- Acronym / sponsor ID
- mCessation in smoking parents
- Conditions
- Smoking Cessation
- Study type
- Interventional
- Recruitment status
- Recruiting
- Enrolment
- 300 participants (estimated)
- Lead sponsor
- Beijing Normal UniversityUniversity, hospital or other
- Study start
- 1 Sep 2025 (actual)
- Primary completion
- 30 Dec 2026 (estimated)
- Study completion
- 30 Dec 2027 (estimated)
- First posted
- 26 Aug 2024 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This study aims to explore the feasibility and preliminary effectiveness of a mobile phone-based intervention tailored specifically for smoking parents.
Detailed description
Parental smoking is associated with numerous adverse outcomes, including exposure to secondhand smoke, heightened risk of respiratory illnesses in children, and an increased likelihood that children will adopt smoking behaviors themselves. Despite awareness of these risks, many parents find it challenging to quit smoking due to stress, lack of support, and time constraints.
This randomized controlled trial (RCT) investigates the effectiveness of a mobile phone-based intervention tailored specifically for smoking parents. The intervention group will receive AI-powered chatbot cessation support, while the control group will be provided with brief cessation advice. The study aims to determine whether the AI-driven intervention is more effective in helping parents quit smoking compared to traditional brief advice.
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind (outcomes assessor)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| AI chatbot support group | Experimental | Behavioral: 5A's/5R's advice, Other: Health warning leaflet, Behavioral: AI-powered chatbot supportAI-powered chatbot support+ 5A's/5R's advice + health warning leaflet |
| Control group | Active comparator | Behavioral: 5A's/5R's advice, Other: Health warning leaflet5A's/5R's advice + health warning leaflet |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (3 listed)
- aged 18 and above, reside in Zhuhai for the next 6 months
- smoke at least 1 cigarette or use e-cigarettes daily
- have a smartphone and a WeChat account, able to use WeChat skillfully
Key exclusion criteria (2 listed)
- Smokers who have communication barrier (either physically or cognitively)
- Smokers who are currently participating in other SC programmes or services
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| 5A's/5R's advice5A's (Ask, Advise, Assess, Assist, Arrange) for smokers who are ready to quit, and 5R's (relevance, risks, rewards, roadblocks, and repetition) for smokers who are not ready to quit. | Behavioural | AI chatbot support group, Control group |
| Health warning leafletThe health warning leaflet provides essential information on the dangers of secondhand and thirdhand smoke. It outlines how exposure to these forms of smoke can harm both smokers and non-smokers, particularly children, by increasing the risk of respiratory illnesses and other health issues. | Other | AI chatbot support group, Control group |
| AI-powered chatbot supportParticipants will receive three months of AI-powered chatbot, equipped with personalized interactions and real-time support, via WeChat. | Behavioural | AI chatbot support group |
Primary outcome
Self-reported 7-day point prevalence quit rate
Time frame: 3 and 6 months follow-up
Self-reported 7-day point prevalence quit rate in the two groups
Eligibility rate
Time frame: baseline
the percentage of eligible smokers out of the total number of smokers screened
2 secondary outcomes
Consent rate
Time frame: baseline
Percentage of Participant Engagement with E-Messages and Counselor Chats
Time frame: 3 months follow-up
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 2 Sep 2026.
- Individual participant dataSharing planned: No
Related trials for Smoking Cessation
Recruiting
Scalable TELeheaLth Cancer CARe: The STELLAR Program to Treat Cancer Risk Behaviors
Obesity, Smoking Cessation
Not yet recruiting
Smoking Cessation Program for Lao People With HIV
Smoking Cessation, HIV
RecruitingPhase 3
Studying NMDA and Sigma-1 in Smoking Cessation Treatment (SUMMIT)
Smoking Cessation
Not yet recruiting
Impacto 2.0: Mobile Smoking Cessation Across Texas
Cigarette Smoking, Smoking Cessation
Not yet recruitingObservational study
PROMETHEE: A Shared Interregional Tele-Tobacco Cessation Platform Embedded Within the IMPULSION Lung Cancer Screening Program
Smoking Cessation, Lung Cancer Screening
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing 5A's/5R's advice, Health warning leaflet and AI-powered chatbot support in people with Smoking Cessation, run by Beijing Normal University at 1 site in China.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 3 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: looking for participants now, as of the sponsor's last update on 2 Sep 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in China. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Xue Weng (3621259, xueweng@bnu.edu.cn), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Self-reported 7-day point prevalence quit rate (time frame: 3 and 6 months follow-up). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 2 Sep 2026; AzTrials last refreshed its copy on 7 Nov 2026.